Beta-D-Glucan in Patients with Haematological Malignancies
(1-3)-beta-D-glucan (BDG) is an almost panfungal marker (absent in zygomycetes and most cryptococci), which can be successfully used in screening and diagnostic testing in patients with haematological malignancies if its advantages and limitations are known. The aim of this review is to report the d...
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
MDPI AG
2021-12-01
|
| Sarja: | Journal of Fungi |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2309-608X/7/12/1046 |